Focus Stocks
Trading Idea - Entry Levels for GlaxoSmithKline
Published on Tuesday, 07 February 2012 09:16 Written by TradersHuddle Wire
New York, February 7th (TradersHuddle.com) - Shares of GlaxoSmithKline plc (NYSE:GSK) finished near calculated support at $43.72.
Current price action with, the U.K. based pharmaceutical and health related consumer products maker closed at $45.09 has left shares at a level that needs to be monitored closely by traders wanting to start or add into a position in the stock.
GlaxoSmithKline's current stock range is defined by current calculated support defined at $43.72 and by the resistance level at $44.65.
The area defined as calculated support, is where we expect for buyers to likely materialize, which could provide a lift to the shares. However, this area if breached will signal participants that the stock failed to entice buyers to step in an support the stock.
Traders wanting to establish a position should pay close attention to GlaxoSmithKline's price action, and establish a position as close to support as possible, but only after buying materializes. Traders should understand that the resistance point at $44.65 might limit their upside, however if the stock breaks resistance, it could be a good point to add to the position.Related Articles
- Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
- Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim® in the U.S.
- Trading Idea: Is GlaxoSmithKline close to Support?
- Close to Key Levels: GlaxoSmithKline
- Trading Idea: Key levels for GlaxoSmithKline
- GlaxoSmithKline Is Near its 50 Day Moving Average
- Stock Futures Lower amid Greek Chaos. Stocks to Watch: AAPL, BAC, CSCO, GSK, M, NEM, TM, DIS
- Is GlaxoSmithKline Closing in to Resistance?
- GlaxoSmithKline Is Near its 50 Day Moving Average
- GlaxoSmithKline Is Near Resistance
Related Partner Headlines
- Bankia Customers Withdraw 1B Euros in One Week: Hot Trends - TheStreet.com
- Pfizer, Glaxo, J&J Grab ASCO Spotlight - TheStreet.com
- GlaxoSmithKline Buys Back 1.35M Shares - Benzinga
- Glaxo's Bid for Human Genome Turns Hostile: Hot Trends - TheStreet.com
- GlaxoSmithKline Stock To Go Ex-dividend Tomorrow (GSK) - TheStreet.com
- GlaxoSmithKline PLC (GSK): Today's Featured Health Care Winner - TheStreet.com
- GlaxoSmithKline PLC (GSK): Today's Featured Health Care Winner - TheStreet.com
- GlaxoSmithKline Stock Hits New 52-Week High (GSK) - TheStreet.com
- Human Genome Rejects $2.6B Bid From GlaxoSmithKline - TheStreet.com
- GlaxoSmithKline Boosts Stake in Theravance - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus -
Continental Resources Names Kirk Kinnear as Vice President of Oil Marketing Logistics









